Reimbursement analysis for medical devices is very complex due to a significant number of technical and clinical nuances which are difficult to capture. That’s why a typical reimbursement mapping project is expensive and takes at least several weeks
High quality off-the-shelf reimbursement reports?
However, we at MTRC, with a group of dedicated clinical coders and reimbursement analysts, have worked hard on overcoming the typical hurdles an analyst faces. By streamlining the processes and establishing a highly professional team whose sole focus is reimbursement coding and analysis, we were able to find a formula for reimbursement reports that will meet the basic needs of our customers, informing them about the market access status for their technology in 11 European countries. Off-the-shelf report with essential information will save you up to 60% to 80% of the budget you usually spend on analyses provided by regular consulting
By focusing on essentials, we could reduce the size of our reports, which translates into affordable pricing. Whilst many established and developing companies often previously struggled to get a good overview of their entire portfolio in key markets due to high cost, our database has now made such an exercise accessible and affordable
These reports can be used by various stakeholders, from industry to investors and corporate finance to get a quick overview of reimbursement statuses for a variety of medical devices
Do you need off-the-shelf report or regular consulting?
Our off-the-shelf reports are performed for a specific number of key indications or clinical scenarios for each technology. However, they might not cover all the possible applications and situations our clients require
If you require a different analysis or need to understand a reimbursement strategy for a technology, we can support you via our general consulting services. Learn more about our consulting services
What is included in our reports?
- Brief overview of the reimbursement system for medical devices
- Procedure coding for technology
- Diagnosis coding
- Payment mechanism for technology
- Reimbursement tariffs for technology
- Policy considerations by payers and policy-makers for technology
- Restrictions in indications or scenarios for use of technology
- Summary of the reimbursement hurdles for technology
Standard reports include analysis for 11 European countries, including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden, and Switzerland